SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?


To: Biotech Jim who wrote (9733)4/27/2015 1:29:58 PM
From: mopgcw  Respond to of 12215
 
Chuckle. I have found myself in that same canoe time and again. Sometimes it is good to just pick up the oars and let the current drive and then dip back in later...how corny eh? but I know your pain.

Ganbatte.



To: Biotech Jim who wrote (9733)4/27/2015 2:12:43 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 12215
 
Resilience here that I wasn't expecting. If mid-biocaps recover here? That would be cool, a reflection of how greed and the sector's years of delivering on promise have not uncoupled. That would be a treat as May approaches.

Brave, your wading in on a day like today.

iphyf finally caught up with Tuck's frustration re. under performance. Bright on dismal day. clls seems to have found a wayward stop to someplace.

juno quite the indicator, but it's really not gone anywhere, basis ~6 months ago. Sort of a daily mini-battleground issue, the sophisticated and intelligent versus the unwashed.....



To: Biotech Jim who wrote (9733)4/27/2015 3:24:07 PM
From: The Ox  Read Replies (3) | Respond to of 12215
 
I counted over 50 biotechs that were down more than 7% at one point earlier today and many are even weaker now....

Unfortunately, it was the wrong day to go long for 90% of this sector!



To: Biotech Jim who wrote (9733)6/1/2015 9:54:39 AM
From: Biotech Jim  Respond to of 12215
 
<How's that buy looking now, smartie pants? >

Well, contrary to some suggestions from friends here, I did hold my JUNO. Those shares bought at 56 and some more at 54, and did a couple additional trades in the mid 40s. After much thinking about the underwater shares, I decided to hold on to them. I figured it JUNO was really a transformative company, that the shares would recover on some good news, and the short interest might help if/when the shorts would cover.

Well, with the new hire of Hyam Levitsky as CSO just reported and the ASCO news over the weekend, the ave price for the new shares are above water. Whew!

Perhaps lucky, smartie pants? Better to be lucky than smart, at least in the short run.